Condition: Peripheral T-Cell Lymphoma With Follicular Helper of T Cell Phenotype · Sponsor: Sun Yat-sen University
This is a prospective, open-label, single arm, multicenter clinical study to evaluate the safety, tolerability, efficacy of chidamide in combination with CHOP in previously untreated peripheral T-cell lymphoma with follicular helper of T cell phenotype
This description comes directly from the study's public registry record.
Qingqing Cai · 0086-20-87342823 · caiqq@sysucc.org.cn
Always discuss trial participation with your own doctor first.
| Sun Yat-sen Universitiy Cancer Center, Sun Yat-Sen University | Guangzhou, Guangdong, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05572983